chemotherapy drug | sciencenewsnet.in

Breaking News

New CWRU study targets suicide risk among LGBTQ+ youth in Cleveland’s child welfare, juvenile justice systems

Architect: Here’s How to Build Homes in Fire-Prone Areas

Study reveals biomarker for high risk of metastasis

BLACK HOLES CAN COOK FOR THEMSELVES, CHANDRA STUDY SHOWS

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients with Cirrhosis and Obesity

Study Results: Exploring Gastric Cancer Risk Through Oral Microbiomes

Children’s Hospital Los Angeles Adds Transformative Gene Therapy and Expands to 10 Treatments, Becoming the Largest Provider of Pediatric Cell and Gene Therapies on the West Coast

Cancer risk established before birth

For Osteoarthritis Patients, Radiation Can Bring Winter Weather Relief

The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine Selected as a U.S. Site for Neuralink Clinical Trial

28 Jan, 2025

Cancer: Combating Chemotherapy Resistance

December 13, 2024 sarah JonasResearch Results

A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug called cisplatin.

Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds

June 27, 2024 sarah JonasResearch Results

• 97% of HER2+, early-stage patients treated with trastuzumab emtansine (T-DM1) were free of cancer recurrence five years after treatment

• Prognostic test (HER2DX) shown helpful in identifying patients at greatest risk for recurrence